FairScope Lab
EN 繁中 简中

PFE

Valuation Healthcare · Drug Manufacturers - General Data as of 2026-03-31

P/E Ratio · Metrics

P/E Ratio

14.97

PEG Ratio

0.61

Dividend Yield

-

Gross Margin

67.26%

Net Margin

18.60%

Revenue CAGR 3Y

-7.88%

ROE

11.93%

ROA

5.18%

Buyback Yield

-0.79%

Current Ratio

1.25

Magic Earn Yield

7.21%

Altman Z-Score

1.80

Fair Value River

Score

Valuation 66
Profitability 37
Growth 0
Health 39
Yield 0
← Back to Dashboard